Our Pipeline
TB Alliance manages the largest pipeline of new TB drugs in history.
]
This position serves as the head of access programs and will be responsible for developing and implementing market interventions, contributing to rapid introduction, and broad access to novel TB regimens in low- and middle-income countries especially those with high incidence of tuberculosis.
The position is broad in scope, with interventions at regional and country level, in collaboration with technical, global health and commercial partners, and will play a pivotal role in creating global access to TB Alliance developed regimens.
The Market Access function at the TB Alliance includes all elements on the value chain including manufacturer relationship management, pricing strategy, forecasting, market understanding, resource mobilization, support for policy change, regulatory issues, diagnostics as well as technical adoption-related issues.
The opening is happening at an exciting time for new TB treatments. TB Alliance has recently developed a novel, short, all-oral treatment for highly resistant TB based on its new drug pretomanid. This treatment, called BPaL, is being implemented in multiple countries. This position represents a rare opportunity to participate in ongoing launch of a new drug and lead its market introduction in several high burden countries in collaboration with partners who are experts in the field.
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.Through innovative science and with partners around the globe, we lead a global effort to ensure development of and equitable access to faster, better tuberculosis cures that will advance global health and prosperity.
With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website: www.tballiance.org.
TB Alliance manages the largest pipeline of new TB drugs in history.